MedPath
HSA Approval

BICALOX TABLETS 50MG

SIN14145P

BICALOX TABLETS 50MG

BICALOX TABLETS 50MG

May 8, 2012

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L02BB03

bicalutamide

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

DOUGLAS MANUFACTURING LTD

Active Ingredients

BICALUTAMIDE

50MG

Bicalutamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BICALOX TABLETS 50MG - HSA Approval | MedPath